Reduced intensity conditioned allograft yields favorable survival for older adults with B‐cell acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Reduced intensity conditioned allograft yields favorable survival for older adults with B‐cell acute lymphoblastic leukemia

Published:2016-11-12 Issue:1 Volume:92 Page:42-49
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Rosko Ashley E.¹,Wang Hai‐Lin²,de Lima Marcos³,Sandmaier Brenda⁴,Khoury H. Jean⁵,Artz Andrew⁶,Brammer Johnathan⁷,Bredeson Christopher⁸,Farag Sherif⁹,Kharfan‐Dabaja Mohamed¹⁰,Lazarus Hillard M.¹¹,Marks David I.¹²,Martino Bufarull Rodrigo¹³,McGuirk Joseph¹⁴,Mohty Mohamed¹⁵,Nishihori Taiga¹⁰,Nivison‐Smith Ian¹⁶,Rashidi Armin¹⁷,Ringden Olle¹⁸¹⁹,Seftel Matthew²⁰,Weisdorf Daniel²¹,Bachanova Veronika²²,Saber Wael²

Affiliation:

1. Division of Hematology, Department of MedicineOhio State UniversityColumbus Ohio

2. Department of Medicine, Medical College of WisconsinCIBMTR, Center for International Blood and Marrow Transplant ResearchMilwaukee Wisconsin

3. Department of Medicine, Seidman Cancer CenterUniversity Hospitals Case Medical CenterCleveland Ohio

4. Division of Medical OncologyUniversity of Washington and Clinical Research Division, Fred Hutchinson Cancer Research CenterSeattle Washington

5. Emory University HospitalAtlanta Georgia

6. Section of Hematology/OncologyUniversity of Chicago School of MedicineChicago Illinois

7. M.D. Anderson Cancer CenterHouston Texas

8. The Ottawa Hospital Blood and Marrow Transplant Program and the Ottawa Hospital Research InstituteOttawa Ontario Canada

9. Indiana University Hospital/Riley Hospital for ChildrenIndianapolis Indianapolis

10. Department of Blood and Marrow TransplantationH. Lee Moffit Cancer Center and Research InstituteTampa Florida

11. Seidman Cancer CenterUniversity Hospitals Case Medical CenterCleveland Ohio

12. Adult Bone Marrow TransplantUniversity Hospitals Bristol NHS TrustBristol United Kingdom

13. Division of Clinical HematologyHospital de la Santa Creu I Sant PauBarcelona Spain

14. University of KansasWestwood Kansas

15. Hopital Saint‐AntoineAPHP, Universite Pierre & Marie Curie, INSERM UMRs U938Paris France

16. St. Vincent's HospitalDarlinghurst New South Wales Australia

17. Barnes Jewish HospitalSt. Louis Missouri

18. Division of Therapeutic Immunology, Department of Laboratory MedicineKarolinska InstitutetStockholm Sweden

19. Centre for Allogeneic Stem Cell TransplantationStockholm Sweden

20. Department of Medical Oncology and HematologyPrincess Margaret Cancer CentreToronto Ontario Canada

21. Divsion of Hematology, Oncology and Transplantation, Department of MedicineUniversity of Minnesota Medical CenterMinneapolis Minnesota

22. Bone and Marrow Transplant ProgramUniversity of Minnesota Medical CenterMinneapolis Minnesota

Funder

Office of Naval Research

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.24575

Reference47 articles.

1. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993

2. Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century

3. Fludarabine, Melphalan and Alemtuzumab conditioned reduced intensity (RIC) allogeneic hematopoietic cell transplantation for adults aged >40 years with de novo acute lymphoblastic leukemia: A prospective study from the UKALL14 trial (ISRCTN 66541317)[abstract];Okasha DKA;Blood,2015

4. A population-based cytogenetic study of adults with acute lymphoblastic leukemia

5. SurveillanceE.End Results (SEER) Program Fast Stats: An interactive tool for access to SEER cancer statistics. Surveillance Research Program National Cancer Institute. Available athttp://seer.cancer.gov/faststats. [Accessed 10.13.2016]

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging CD19CAR T cells early in the treatment of older patients with B-ALL: are we there yet?;Leukemia & Lymphoma;2024-01-05

2. Donor-derived CD19 CAR-T Cells versus Chemotherapy Plus Donor Lymphocyte Infusion for Treatment of Recurrent CD19-positive B-ALL After Allogeneic Hematopoietic Stem Cell Transplantation;Current Medical Science;2023-06-17

3. Allogeneic stem cell transplant outcomes between TBI-containing reduced intensity and myeloablative conditioning regimens for ALL in complete remission;Leukemia & Lymphoma;2023-05-08

4. Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years—a registry-based study by the Acute Leukemia Working Party of the EBMT;Bone Marrow Transplantation;2023-05-05

5. Expert Recommendations for the Diagnosis, Treatment, and Management of Adult B-Cell Acute Lymphoblastic Leukemia in Latin America;JCO Global Oncology;2023-05